Acyltransferase polynucleotides, polypeptides and methods of use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 20, 2018
Grant Date -
Oct 8, 2015
app pub date -
Oct 22, 2013
filing date -
Oct 30, 2012
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provides chimeric DGAT1 proteins comprising: a) at their N-terminal ends, an N-terminal portion of a first DGAT1 protein, and b) at their C-terminal ends, a C-terminal portion of a second DGAT1 protein. The chimeric DGAT proteins show enhanced activity relative to at least one of the first DGAT1 protein and the second DGAT1 protein. The chimeric DGAT proteins of the invention can be expressed in cells to increase cellular lipid accumulation and/or modify the cellular lipid profile. The invention also provides polynucleotides encoding the chimeric DGAT1 proteins, cells and compositions comprising the polynucleotides or chimeric DGAT1 proteins, and methods using the chimeric DGAT1 proteins to produce oil.
First Claim
Other Claims data not available
Family
International Classification(s)
- 2013 Application Filing Year
- C12P Class
- 1593 Applications Filed
- 1388 Patents Issued To-Date
- 87.14 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- C12P Class
- 0 % this patent is cited more than
- 7 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Aug 20, 2025 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Aug 20, 2029 |
